J Clin Neurol.  2019 Jul;15(3):393-394. 10.3988/jcn.2019.15.3.393.

Refractory Nonconvulsive Status Epilepticus with Favorable Outcome in a Patient with Marchiafava-Bignami Disease

• Kim R
• Cho HJ
• Lee HW
• Jun JS

• KMID: 2451125
• DOI: http://doi.org/10.3988/jcn.2019.15.3.393

Abstract

No abstract available.

MeSH Terms

Humans
Marchiafava-Bignami Disease*
Status Epilepticus*

Figure

• 

  Fig. 1 MRI findings. The initial MRI revealed increased signal intensities in the splenium and genu of the corpus callosum and the cerebral cortex in DWI (A and B) and axial FLAIR imaging (C and D). Follow-up MRI performed 1 month later revealed complete resolution of the abnormal DWI signals (E and F), but persistent lesion hyperintensities with some atrophic changes were observed on axial FLAIR images (G and H) and sagittal T2-weighted images (I). DWI: diffusion-weighted imaging, FLAIR: fluid-attenuated inversion recovery, MRI: magnetic resonance imaging.

Reference

1. Hillbom M, Saloheimo P, Fujioka S, Wszolek ZK, Juvela S, Leone MA. Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases. J Neurol Neurosurg Psychiatry. 2014; 85:168–173.

2. Navarro JF, Noriega S. Marchiafava-Bignami disease. Rev Neurol. 1999; 28:519–523.

3. O'Connor CM. Alcohol abuse and dependence (chap 32). In : Goldman L, Schafer AI, editors. Goldman-Cecil Medicine. 24th ed. Philadelphia: Elsevier Saunders;2012.

4. Rogawski MA. Update on the neurobiology of alcohol withdrawal seizures. Epilepsy Curr. 2005; 5:225–230.

5. Fernández-Torre JL, Kaplan PW. Subacute encephalopathy with seizures in alcoholics (SESA syndrome) revisited. Seizure. 2014; 23:393–396.

6. Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J Neurol. 2004; 251:1050–1059.